omniture
logo
Search
Keen Vision Acquisition Corporation
Media Room

Latest News

rss

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology

* Traditional methods for evaluating therapeutic efficacy and cardiotoxicity often lead to high f...

2024-10-31 20:00 1080

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over...

2024-10-24 20:00 1200

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation

* Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardio...

2024-09-05 20:00 2545

Keen Vision Acquisition Corporation Announces Closing of $149,500,000 Initial Public Offering and Full Exercise of Over-Allotment Option

SUMMIT, N.J., July 27, 2023 /PRNewswire/ -- Keen Vision Acquisition Corporation (the "Company") ann...

2023-07-28 04:00 4717

Keen Vision Acquisition Corporation Announces Pricing of $130,000,000 Initial Public Offering

SUMMIT, N.J., July 24, 2023 /PRNewswire/ -- Keen Vision Acquisition Corporation (the "Company") ann...

2023-07-25 05:30 3454